LGR5 and colorectal carcinoma: When LGR5+ CSCs were ablated via CRISPR-based strategies in CRC organoids, tumors initially regressed; however, they subsequently regrew owing to lineage plasticity, as LGR5− differentiated cells reacquired stemness and regenerated the LGR5+ pool [23,24].